Series B - Alebund Pharmaceuticals - Sep 13, 2021 Funding Round Profile - Cointime

Bitcoin $98,955.93 +1.66%
Ethereum $3,318.34 -0.54%
BNB $624.88 +0.73%
Optimism $2.16 +0.95%
Arbitrum $0.79 -0.87%
Solana $255.83 +1.02%
Polygon $0.47 +4.72%
Cosmos $7.33 +16.41%
Avalanche $39.79 +12.72%

Bitcoin $98,955.93 +1.66%
Ethereum $3,318.34 -0.54%
BNB $624.88 +0.73%
Optimism $2.16 +0.95%
Arbitrum $0.79 -0.87%
Solana $255.83 +1.02%
Polygon $0.47 +4.72%
Cosmos $7.33 +16.41%
Avalanche $39.79 +12.72%

Alebund Pharmaceuticals

company

Funding Round

Series B

Money Raised

$ 54.50M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Lilly Asia Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
May 9, 2021	Series B	$ 60M	Lilly Asia Ventures	Detail
Jan 1, 2020	Series A	0	Lilly Asia Ventures	Detail